Profund Advisors LLC decreased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,839 shares of the company’s stock after selling 1,086 shares during the period. Profund Advisors LLC’s […]